VIMIZIM
Google image searchProduct monograph
Active ingredient
elosulfase alfa, 1 MG/ML
DIN: 02427184
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: 5MG/5ML. SINGLE-USE VIAL
Schedule: Prescription / Schedule D
Company: BIOMARIN INTERNATIONAL LIMITED
Date: 27-AUG-2014
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AB — Enzymes (ATC, ATC/DDD)
- A16AB12 — ELOSULFASE ALFA (ATC/DDD)
Reference brand drug: Vimizim
